Revised Growth Hormone Clinical Prior Authorization Begins April 1, 2020

Revised Growth Hormone Clinical Prior Authorization Begins April 1, 2020

FirstCare will implement the Growth Hormone clinical prior authorization criteria on April 1, 2020. All clinical edit criteria can be found here. The implementation will include four diagnosis codes for approval as suggested by MCOs and approved by VDP:
  • Q87.11: Prader-Willi Syndrome
  • Q87.19: Noonan Syndrome
  • E34.3: SHOX deficiency with Dyschondrosteosis
  • Q78.8: SHOX deficiency with short stature

Send to a Friend

* Required field

Captcha The math problem above is intended to reduce spam.